Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
2017 · Science · 4,526 citations
https://doi.org/10.1126/science.aan4236
C
Christine N. Spencer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
241
Papers
12.1K
Citations
17
h-index
26
i10-index
Christine N. Spencer is an academic researcher from Parker Institute for Cancer Immunotherapy. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Immune cells in cancer. The author has an h-index of 17, co-authored 205 publications.
ORCID: 0000-0002-1304-4390Papers by this author
worksB cells and tertiary lymphoid structures promote immunotherapy response
2020 · Nature · 2,551 citations
https://doi.org/10.1038/s41586-019-1922-8
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma
2020 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-020-15538-9
Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
2023 · JAMA Dermatology · 22 citations
https://doi.org/10.1001/jamadermatol.2023.2955
Supplementary Table S6 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26134509
Supplementary Figure S13 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26134590
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat